KBC Group’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-843
Closed -$16K 1861
2023
Q3
$16K Sell
843
-217
-20% -$4.12K ﹤0.01% 1899
2023
Q2
$28K Hold
1,060
﹤0.01% 1451
2023
Q1
$30K Hold
1,060
﹤0.01% 1464
2022
Q4
$31K Hold
1,060
﹤0.01% 1472
2022
Q3
$25K Hold
1,060
﹤0.01% 1493
2022
Q2
$24K Buy
+1,060
New +$24K ﹤0.01% 1515
2021
Q1
Sell
-3,078
Closed -$767K 1284
2020
Q4
$767K Hold
3,078
﹤0.01% 1171
2020
Q3
$108K Hold
3,078
﹤0.01% 1177
2020
Q2
$116K Sell
3,078
-5,476
-64% -$206K ﹤0.01% 1204
2020
Q1
$247K Sell
8,554
-18,577
-68% -$536K ﹤0.01% 988
2019
Q4
$1.41M Buy
27,131
+12,266
+83% +$636K 0.01% 786
2019
Q3
$816K Buy
14,865
+3,397
+30% +$186K 0.01% 937
2019
Q2
$466K Sell
11,468
-12,472
-52% -$507K ﹤0.01% 1080
2019
Q1
$724K Buy
23,940
+12,969
+118% +$392K 0.01% 966
2018
Q4
$369K Sell
10,971
-7,350
-40% -$247K ﹤0.01% 999
2018
Q3
$773K Buy
+18,321
New +$773K 0.01% 1000
2018
Q2
Sell
-6,607
Closed -$329K 1292
2018
Q1
$329K Sell
6,607
-6,835
-51% -$340K ﹤0.01% 1052
2017
Q4
$725K Hold
13,442
0.01% 890
2017
Q3
$780K Sell
13,442
-5,411
-29% -$314K 0.01% 872
2017
Q2
$930K Sell
18,853
-8,210
-30% -$405K 0.01% 797
2017
Q1
$1.18M Sell
27,063
-399
-1% -$17.3K 0.01% 809
2016
Q4
$1.35M Buy
27,462
+11,273
+70% +$552K 0.01% 761
2016
Q3
$775K Buy
16,189
+8,050
+99% +$385K 0.01% 843
2016
Q2
$437K Buy
8,139
+7,740
+1,940% +$416K 0.01% 913
2016
Q1
$18K Hold
399
﹤0.01% 1232
2015
Q4
$15K Buy
+399
New +$15K ﹤0.01% 1241
2014
Q4
Sell
-3,841
Closed -$141K 1429
2014
Q3
$141K Hold
3,841
﹤0.01% 1071
2014
Q2
$178K Hold
3,841
﹤0.01% 1089
2014
Q1
$158K Hold
3,841
﹤0.01% 1032
2013
Q4
$147K Buy
+3,841
New +$147K ﹤0.01% 1069